1
|
Falkenberg SM, Ma H, Casas E, Dassanayake RP, Bolton MW, Raithel G, Silvis S, Neill JD, Walz PH. Multivariate Analysis as a Method to Evaluate Antigenic Relationships between Bovine Viral Diarrhea Virus 1b Isolates and Vaccine Strains. Viruses 2023; 15:2085. [PMID: 37896862 PMCID: PMC10612043 DOI: 10.3390/v15102085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2023] [Revised: 10/09/2023] [Accepted: 10/10/2023] [Indexed: 10/29/2023] Open
Abstract
The antigenicity of bovine viral diarrhea virus (BVDV) has been evaluated using virus-neutralizing titer data analyzed by principal component analysis (PCA) and has demonstrated numerous isolates to be antigenically divergent from US vaccine strains. The lack of BVDV-1b strains in currently licensed vaccines has raised concerns regarding the lack of protection against BVDV-1b field strains. The aim of this study was to evaluate the antigenic diversity of BVDV-1b strains and better understand the breadth of antigenic relatedness using BVDV-1b antisera and antisera from vaccine strains. Results from this analysis demonstrate the antigenic diversity observed among BVDV-1b isolates and genetic assignment into the BVDV-1b subgenotype is not representative of antigenic relatedness. This is demonstrated by BVDV-1b isolates (2280N, SNc, Illc, MSU, and 2337) observed to be as antigenically dissimilar as BVDV-2a isolates when using BVDV-1b antisera. Additionally, when BVDV-1a vaccine antisera was used for comparisons, a greater percentage of BVDV-1b isolates clustered with BVDV-1a vaccine strains as part of PC1, suggesting antigenic relatedness and potentially partial protection. Collectively, data from this study would suggest that while most BVDV-1b isolates are antigenically similar, there are antigenically dissimilar BVDV-1b isolates as determined by the lack of cross-reactivity, which may contribute to the lack of protection.
Collapse
Affiliation(s)
- Shollie M. Falkenberg
- Sugg Laboratory, Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA (S.S.); (P.H.W.)
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA 50010, USA (J.D.N.)
| | - Hao Ma
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA 50010, USA (J.D.N.)
| | - Eduardo Casas
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA 50010, USA (J.D.N.)
| | - Rohana P. Dassanayake
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA 50010, USA (J.D.N.)
| | | | - Gage Raithel
- Sugg Laboratory, Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA (S.S.); (P.H.W.)
| | - Scott Silvis
- Sugg Laboratory, Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA (S.S.); (P.H.W.)
| | - John D. Neill
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA 50010, USA (J.D.N.)
| | - Paul H. Walz
- Sugg Laboratory, Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA (S.S.); (P.H.W.)
| |
Collapse
|
2
|
Grange G, Mindeguia M, Gisbert P, Meyer G. Cross-Neutralization between Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2 after Vaccination with a BVDV-1a Modified-Live-Vaccine. Vaccines (Basel) 2023; 11:1204. [PMID: 37515020 PMCID: PMC10383975 DOI: 10.3390/vaccines11071204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Revised: 07/03/2023] [Accepted: 07/04/2023] [Indexed: 07/30/2023] Open
Abstract
Control of Bovine Viral Diarrhea Virus types 1 and 2 (BVDV-1 and BVDV-2) involves removing persistently infected animals from the herd, ensuring the biosecurity level of the farms and vaccination for the prevention of fetal infection. Given pestiviruses high genetic and antigenic diversities, one challenge for a BVDV vaccine is to provide the broadest possible heterologous protection against most genotypes and sub-genotypes. The Modified-Live Mucosiffa® vaccine, which contains the BVDV-1 sub-genotype 1a (BVDV-1a) cytopathic Oregon C24 strain, was shown to protect fetuses of pregnant heifers against a challenge with a BVDV-1f Han strain. In this study, we tested the cross-neutralizing antibody (NA) response of 9 heifers at 28, 203- and 363-days post-vaccination with Mucosiffa® against recent and circulating European strains of BVDV-1a, -1b, -1e, -1f and BVDV-2a. We showed that Mucosiffa® vaccination generates a stable over time NA response against all BVDV strains. NA response was greater against BVDV-1a and -1b, with no significant differences between these sub-genotypes. Interestingly the NA response against the two BVDV-2a strains was similar to that observed against the BVDV-1f Han strain, which was the challenge strain used in fetal protection studies to validate the Mucosiffa® vaccine. These results suggest that Mucosiffa® vaccination provides humoral cross-immunity, which may protect against BVDV-1 and BVDV-2a infection.
Collapse
Affiliation(s)
| | - Marie Mindeguia
- Clinique Vétérinaire Amikuze, 64120 Béhasque-Lapiste, France
| | | | - Gilles Meyer
- Interactions Hôtes-Agents Pathogènes (IHAP), Université de Toulouse, INRAE, ENVT, 31100 Toulouse, France
| |
Collapse
|
3
|
Perkins-Oines S, Dias N, Krafsur G, Abdelsalam K, Perry G, Ensley D, Jones C, Chase CCL. The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica. Vaccine 2023; 41:3080-3091. [PMID: 37045678 DOI: 10.1016/j.vaccine.2023.04.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2023] [Revised: 03/28/2023] [Accepted: 04/03/2023] [Indexed: 04/14/2023]
Abstract
Bovine respiratory disease is the greatest threat to calf health. In this study, colostrum-fed dairy X beef calves were vaccinated at ∼30 days of age with an adjuvanted parenteral vaccine containing modified live bovine viral diarrhea virus (BVDV) type 1 and type 2, bovine herpesvirus 1 (BHV-1), bovine parainfluenza type 3 virus (PI3V) and bovine respiratory syncytial virus (BRSV) andM. haemolyticatoxoid (Group 1), or intranasal temperature-sensitive BHV-1, BRSV and PI3V concurrently witha parenteral vaccine containing modified live BVDV type 1 and type 2 andM. haemolyticatoxoid (Group 2) or a placebo (Group 3). The calves were challenged ∼150 days post vaccination intranasally with BVDV 1b and then 7 days later intratracheally withM. haemolytica. The calves wereeuthanized 6 days after theM. haemolyticachallenge. Clinical signs following BVDV infection were similar in all groups. There was increased rectal temperatures in the Groups 2 and 3 on day 3 and in Group 3 on days 8-13. Group 1 animals had a slight leukopenia following BVDV infection while Groups 2 and 3 had greater leukopenia. BVDV type 1 and 2 serum titers increased in Group 1 following vaccination while these titers waned in Groups 2 and 3. There were higher levels of BVDV in the buffy coats and nasal samples in Group 2 and Group 3 versus Group 1 (p < 0.01). Interferon-gamma response was higher (p < 0.01) in Group 1 animals than Groups 2 and 3. Group 1 had the lowest percent pneumonic tissue (1.6%) while Group 2 vaccinates had 3.7% and the control Group 3 was 5.3%. Vaccination in the face of maternal antibody with a parenteral adjuvanted vaccine resulted in better protection than the regimen of an intranasal vaccine anda parenteral adjuvanted BVDV andM haemolyticacombination vaccine in a BVDV-M. haemolyticadual challenge.
Collapse
Affiliation(s)
| | | | | | | | - George Perry
- Texas A&M AgriLife Research and Extension Center, Overton, TX, United States
| | - Douglas Ensley
- Boehringer Ingelheim Animal Health, Duluth, GA, United States
| | - Craig Jones
- Boehringer Ingelheim Animal Health, Duluth, GA, United States
| | - Christopher C L Chase
- RTI LLC, Brookings, SD 57006, United States; Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD, United States.
| |
Collapse
|
4
|
Rivas J, Hasanaj A, Deblon C, Gisbert P, Garigliany MM. Genetic diversity of Bovine Viral Diarrhea Virus in cattle in France between 2018 and 2020. Front Vet Sci 2022; 9:1028866. [PMID: 36304414 PMCID: PMC9593101 DOI: 10.3389/fvets.2022.1028866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2022] [Accepted: 09/23/2022] [Indexed: 11/04/2022] Open
Abstract
Bovine Viral Diarrhea Virus (BVDV) is one of the main pathogens that affects ruminants worldwide, generating significant economic losses. Like other RNA viruses, BVDV is characterized by a high genetic variability, generating the emergence of new variants, and increasing the risk of new outbreaks. The last report on BVDV genotypes in France was in 2008, since which there have been no new information. The goal of this study is to determine the genetic diversity of BVDV strains currently circulating in France. To this aim, samples of cattle were taken from different departments that are part of the main areas of livestock production during the years 2018 to 2020. Using the partial sequence of the 5'UTR region of the viral genome, we identified and classified 145 samples corresponding to Pestivirus A and one sample corresponding to Pestivirus D. For the Pestivirus A samples, the 1e, 1b, 1d, and 1l genotypes, previously described in France, were identified. Next, the 1r and 1s genotypes, not previously described in the country, were detected. In addition, a new genotype was identified and was tentatively assigned as 1x genotype. These results indicate an increase in the genetic diversity of BVDV in France.
Collapse
Affiliation(s)
- José Rivas
- Fundamental and Applied Research for Animals and Health (FARAH), Faculty of Veterinary Medicine, University of Liège, Liège, Belgium
| | - Alesia Hasanaj
- Fundamental and Applied Research for Animals and Health (FARAH), Faculty of Veterinary Medicine, University of Liège, Liège, Belgium
| | - Caroline Deblon
- Fundamental and Applied Research for Animals and Health (FARAH), Faculty of Veterinary Medicine, University of Liège, Liège, Belgium
| | | | - Mutien-Marie Garigliany
- Fundamental and Applied Research for Animals and Health (FARAH), Faculty of Veterinary Medicine, University of Liège, Liège, Belgium,*Correspondence: Mutien-Marie Garigliany
| |
Collapse
|
5
|
Do modified live virus vaccines against bovine viral diarrhea induce fetal cross-protection against HoBi-like Pestivirus? Vet Microbiol 2021; 260:109178. [PMID: 34330023 DOI: 10.1016/j.vetmic.2021.109178] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2021] [Accepted: 07/04/2021] [Indexed: 11/22/2022]
Abstract
Bovine Pestivirus heterogeneity is a major challenge for vaccines against bovine viral diarrhea (BVD). In breeding herds, fetal protection is a high priority issue. To some degree, fetal infections in vaccinated heifers have been attributed to the antigenic diversity of bovine Pestiviruses. The purpose of this study was to assess fetal protection against a divergent bovine Pestivirus (Hobi-like Pestivirus, HoBiPeV) with a commercially available modified live vaccine (MLV) claiming fetal protection against BVDV 1 and BVDV 2 up to one year after the first inoculation. Five vaccinated and four unvaccinated heifers were challenged by intranasal inoculation with the HoBiPeV Italy-1/10-1 strain between 82 and 89 days after insemination, i.e. between 4 and 6 months after vaccination. At challenge, neutralizing antibody titers to HoBiPeV in vaccinated heifers were low or even undetectable. Of the four unvaccinated heifers, one control animal aborted (fetus not available) and the remaining three gave birth to HoBiPeV positive calves. Among the heifers of the vaccinated group, one aborted the fetus in the sixth month of pregnancy, which tested Pestivirus negative, while three others gave birth to healthy, HoBiPeV negative calves; the remaining heifer delivered one HoBiPeV positive calf. The results suggest that the BVDV vaccine might be able to elicit a partial fetal protection against HobiPeV, even in absence of a strong specific antibody response.
Collapse
|
6
|
Walz PH, Chamorro MF, M Falkenberg S, Passler T, van der Meer F, R Woolums A. Bovine viral diarrhea virus: An updated American College of Veterinary Internal Medicine consensus statement with focus on virus biology, hosts, immunosuppression, and vaccination. J Vet Intern Med 2020; 34:1690-1706. [PMID: 32633084 PMCID: PMC7517858 DOI: 10.1111/jvim.15816] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 05/11/2020] [Accepted: 05/11/2020] [Indexed: 12/01/2022] Open
Abstract
Control of bovine viral diarrhea virus (BVDV) in cattle populations across most of the world has remained elusive in spite of advances in knowledge about this viral pathogen. A central feature of virus perseverance in cattle herds is the unique mechanism of persistent infection. Managing BVDV infection in herds involves controlling persistently infected carrier animals using a multidimensional approach of vaccination, biosecurity, and identification of BVDV reservoirs. A decade has passed since the original American College of Veterinary Internal Medicine consensus statement on BVDV. While much has remained the same with respect to clinical signs of disease, pathogenesis of infection including persistent infection, and diagnosis, scientific articles published since 2010 have led to a greater understanding of difficulties associated with control of BVDV. This consensus statement update on BVDV presents greater focus on topics currently relevant to the biology and control of this viral pathogen of cattle, including changes in virus subpopulations, infection in heterologous hosts, immunosuppression, and vaccination.
Collapse
Affiliation(s)
- Paul H Walz
- College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA
| | - Manuel F Chamorro
- College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA
| | - Shollie M Falkenberg
- USDA Agricultural Research Service, National Animal Disease Center, Ames, Iowa, USA
| | - Thomas Passler
- College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA
| | - Frank van der Meer
- Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Amelia R Woolums
- College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi, USA
| |
Collapse
|
7
|
Fulton RW, Cook BJ, Payton ME, Burge LJ, Step D. Immune response to bovine viral diarrhea virus (BVDV) vaccines detecting antibodies to BVDV subtypes 1a, 1b, 2a, and 2c. Vaccine 2020; 38:4032-4037. [DOI: 10.1016/j.vaccine.2020.03.058] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2020] [Revised: 03/27/2020] [Accepted: 03/29/2020] [Indexed: 10/24/2022]
|
8
|
Falkenberg SM, Dassanayake RP, Neill JD, Walz PH, Casas E, Ridpath JF, Roth J. Measuring CMI responses using the PrimeFlow RNA assay: A new method of evaluating BVDV vaccination response in cattle. Vet Immunol Immunopathol 2020; 221:110024. [PMID: 32070831 DOI: 10.1016/j.vetimm.2020.110024] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2019] [Revised: 01/22/2020] [Accepted: 02/10/2020] [Indexed: 12/24/2022]
Abstract
Current methods for evaluating bovine viral diarrhea virus (BVDV) vaccination response typically rely on measurement of humoral responses as determined by virus neutralizing antibody titers (VNT) against BVDV. While VNT are correlated with increased protection, research has also shown that cell mediated immunity (CMI) is an important component of a protective response against BVDV. For example, improved protection against BVDV by modified-live viral (MLV) vaccines as compared to killed vaccines is thought to be due to better CMI induced by the MLV. The goal of this work was to evaluate the cell mediated response in vaccinated calves using a novel PrimeFlow RNA assay that incorporates cell surface marker staining with intracellular RNA expression of cytokines and viral RNA detection. Results from this study evaluating mRNA for IFN-γ and IL-2 at 24 h post-BVDV stimulation are similar to previous studies in which IFN-γ was detected in the CD4+ and CD8+ T cell population. However, a novel observation was the detection of IFN-γ mRNA in the NK cell population in vaccinated animals. The NK cell population contributed a significant portion of the IFN-γ produced. This study also demonstrated a decrease in the frequency and amount of BVDV in PBMCs, harvested from vaccinated calves and exposed to BVDV in vitro. Collectively data from this study highlights the association between an increase in IFN-γ and a decreased infection rate of isolated PBMC's, based on the frequency and amount of BVDV positive cells following in vitro exposure. This new method combines not only the ability to evaluate cellular responses, but also the ability to understand potential antiviral properties associated with cellular responses. This is the first assay to describe and simultaneously measure CMI responses and intracellular viral RNA quantity as a method to evaluate protective responses associated with vaccination.
Collapse
Affiliation(s)
- Shollie M Falkenberg
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA, 50010, United States.
| | - Rohana P Dassanayake
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA, 50010, United States
| | - John D Neill
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA, 50010, United States
| | - Paul H Walz
- Department of Pathobiology, College of Veterinary Medicine, 129 Sugg Laboratory, Auburn University, AL, 36849, United States
| | - Eduardo Casas
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA, 50010, United States
| | - Julia F Ridpath
- Ruminant Disease and Immunology Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA, 50010, United States
| | - James Roth
- Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, Iowa State University, IA, United States
| |
Collapse
|
9
|
Neill JD, Workman AM, Hesse R, Bai J, Porter EP, Meadors B, Anderson J, Bayles DO, Falkenberg SM. Identification of BVDV2b and 2c subgenotypes in the United States: Genetic and antigenic characterization. Virology 2018; 528:19-29. [PMID: 30553108 DOI: 10.1016/j.virol.2018.12.002] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2018] [Revised: 12/03/2018] [Accepted: 12/03/2018] [Indexed: 01/22/2023]
Abstract
Bovine viral diarrhea virus (BVDV), a ubiquitous pathogen of cattle, causes subclinical to severe acute disease. Two species of BVDV are recognized, BVDV1 and BVDV2 with BVDV1 divided into at least 21 subgenotypes and BVDV2 into 3-4 subgenotypes, most commonly using sequences from the 5' untranslated region (5' UTR). We report genomic sequencing of 8 BVDV2 isolates that did not segregate into the 2a subgenotype; but represented two additional BVDV2 subgenotypes. One BVDV2 subgenotype was previously recognized only in Asia. The other seven viruses fell into a second subgenotype that was first reported in Brazil and the U.S. in 2002. Neutralization assays using antiserum raised against vaccine strain BVDV2a 296c revealed varying degrees of neutralization of genetically diverse BVDV2 isolates. Neutralization titers decreased from 1.8 to more than a four log(2) decrease. This study illustrated the considerable genetic and antigenic diversity in BVDV2 circulating in the U.S.
Collapse
Affiliation(s)
- John D Neill
- Ruminant Diseases and Immunology Research Unit, National Animal Disease Center, USDA, ARS, Ames, IA 50010, USA.
| | - Aspen M Workman
- US Meat Animal Research Center, USDA, ARS, Clay Center, NE 68933, USA
| | - Richard Hesse
- Kansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, 66502 USA
| | - Jianfa Bai
- Kansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, 66502 USA
| | - Elizabeth Poulsen Porter
- Kansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, 66502 USA
| | - Barbara Meadors
- Kansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, 66502 USA
| | - Joe Anderson
- Kansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, 66502 USA
| | - Darrell O Bayles
- Ruminant Diseases and Immunology Research Unit, National Animal Disease Center, USDA, ARS, Ames, IA 50010, USA
| | - Shollie M Falkenberg
- Ruminant Diseases and Immunology Research Unit, National Animal Disease Center, USDA, ARS, Ames, IA 50010, USA
| |
Collapse
|
10
|
Walz PH, Riddell KP, Newcomer BW, Neill JD, Falkenberg SM, Cortese VS, Scruggs DW, Short TH. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2. Vaccine 2018; 36:3853-3860. [PMID: 29699786 DOI: 10.1016/j.vaccine.2018.04.005] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Revised: 03/28/2018] [Accepted: 04/03/2018] [Indexed: 11/26/2022]
Abstract
Bovine viral diarrhea virus (BVDV) is an important viral cause of reproductive disease, immune suppression and clinical disease in cattle. The objective of this study was to compare reproductive protection in cattle against the impacts of bovine viral diarrhea virus (BVDV) provided by three different multivalent vaccines containing inactivated BVDV. BVDV negative beef heifers and cows (n = 122) were randomly assigned to one of four groups. Groups A-C (n = 34/group) received two pre-breeding doses of one of three commercially available multivalent vaccines containing inactivated fractions of BVDV 1 and BVDV 2, and Group D (n = 20) served as negative control and received two doses of saline prior to breeding. Animals were bred, and following pregnancy diagnosis, 110 cattle [Group A (n = 31); Group B (n = 32); Group C (n = 31); Group D (n = 16)] were subjected to a 28-day exposure to cattle persistently infected (PI) with BVDV (1a, 1b and 2a). Of the 110 pregnancies, 6 pregnancies resulted in fetal resorption with no material for testing. From the resultant 104 pregnancies, BVDV transplacental infections were demonstrated in 73 pregnancies. The BVDV fetal infection rate (FI) was calculated at 13/30 (43%) for Group A cows, 27/29 (93%) for Group B cows, 18/30 (60%) for Group C cows, and 15/15 (100%) for Group D cows. Statistical differences were observed between groups with respect to post-vaccination antibody titers, presence and duration of viremia in pregnant cattle, and fetal infection rates in offspring from BVDV-exposed cows. Group A vaccination resulted in significant protection against BVDV infection as compared to all other groups based upon outcome measurements, while Group B vaccination did not differ in protection against BVDV infection from control Group D. Ability of inactivated BVDV vaccines to provide protection against BVDV fetal infection varies significantly among commercially available products; however, in this challenge model, the inactivated vaccines provided unacceptable levels of BVDV FI protection.
Collapse
Affiliation(s)
- Paul H Walz
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA
| | - Kay P Riddell
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA
| | | | - John D Neill
- USDA, Agricultural Research Service, National Animal Disease Center, Ruminant Diseases and Immunology Research Unit, Ames, IA 50010, USA
| | - Shollie M Falkenberg
- USDA, Agricultural Research Service, National Animal Disease Center, Ruminant Diseases and Immunology Research Unit, Ames, IA 50010, USA
| | | | | | | |
Collapse
|
11
|
Peddireddi L, Foster KA, Poulsen EG, An B, Hoang QH, O'Connell C, Anderson JW, Thomson DU, Hanzlicek GA, Bai J, Hesse RA, Oberst RD, Anderson GA, Leyva-Baca I. Molecular detection and characterization of transient bovine viral diarrhea virus (BVDV) infections in cattle commingled with ten BVDV persistently infected cattle. J Vet Diagn Invest 2018; 30:413-422. [PMID: 29322882 DOI: 10.1177/1040638717753962] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Fifty-three cattle of unknown serologic status that were not persistently infected (PI) with bovine viral diarrhea virus (BVDV) were commingled with 10 cattle that were PI with different strains of BVDV, and were monitored for an extended commingle period using a reverse-transcription real-time PCR (RT-rtPCR) BVDV assay on various sample types. Transient infections with BVDV were also assessed by virus isolation, virus neutralization (VN) assays, and direct buffy coat 5'-UTR sequencing. Infections were demonstrated in all cattle by RT-rtPCR; however, the detection rate was dependent on the type of sample. Buffy coat samples demonstrated a significantly greater number of positive results ( p ≤ 0.05) than either serum or nasal swab samples. Presence of elevated BVDV VN titers at the onset inversely correlated with the number of test days positive that an individual would be identified by RT-rtPCR from buffy coat samples, and directly correlated with the average Ct values accumulated over all RT-rtPCR test days from buffy coat samples. Both single and mixed genotype/subgenotype/strain infections were detected in individual cattle by direct sample 5'-UTR sequencing. A BVDV-2a strain from a PI animal was found to be the predominant strain infecting 64% of all non-PI cattle; BVDV-1b strains originating from 3 PI cattle were never detected in non-PI cattle. Although direct sample 5'-UTR sequencing was capable of demonstrating mixed BVDV infections, identifying all strains suspected was not always efficient or possible.
Collapse
Affiliation(s)
- Lalitha Peddireddi
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Kelly A Foster
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Elizabeth G Poulsen
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Baoyan An
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Quoc Hung Hoang
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Catherine O'Connell
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Joseph W Anderson
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Daniel U Thomson
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Gregg A Hanzlicek
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Jianfa Bai
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Richard A Hesse
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Richard D Oberst
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Gary A Anderson
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| | - Ivan Leyva-Baca
- Kansas State Veterinary Diagnostic Laboratory (Peddireddi, An, Poulsen, JW Anderson, Hanzlicek, Bai, Oberst, GA Anderson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Department of Diagnostic Medicine/Pathobiology (Foster, Thomson), College of Veterinary Medicine, Kansas State University, Manhattan, KS.,Animal Health Group, Thermo Fisher Scientific, Austin, TX (Hoang, O'Connell).,Life Technologies, Austin, TX (Leyva-Baca)
| |
Collapse
|
12
|
Fulton RW, Confer AW, Sorensen NJ, Ridpath JF, Burge LJ. Bovine viral diarrhea virus 1b fetal infection with extensive hemorrhage. J Vet Diagn Invest 2017; 29:880-884. [PMID: 28803536 DOI: 10.1177/1040638717726825] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Bovine viral diarrhea virus (BVDV) 1b was isolated from tissues of a term bovine fetus with petechial hemorrhages noted throughout the body and placenta at autopsy. Fresh lung, kidney, thymus, and liver tissues were examined by direct fluorescent antibody testing and were positive for BVDV antigen and negative for bovine herpesvirus 1 antigen. An organ pool of fresh tissues was positive for noncytopathic (NCP) BVDV-1 by virus isolation. BVDV-1b was identified by sequencing of the 5'-UTR region of the genome. Fixed brain, placenta, thymus, lymph node, lung, kidney, skeletal muscle, liver, and bone marrow were positive for BVDV antigen by immunohistochemistry. Although BVDV hemorrhage and/or thrombocytopenia has been associated historically with NCP strains of BVDV-2, this case adds to more recent reports of BVDV-1 infections and hemorrhage in cattle. This BVDV-1b isolate should be investigated for its potential to cause hemorrhage in postnatal cattle.
Collapse
Affiliation(s)
- Robert W Fulton
- Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, OK (Fulton, Confer, Sorensen, Burge).,U.S. Department of Agriculture, Agriculture Research Service, National Animal Disease Center, Ames, IA (Ridpath)
| | - Anthony W Confer
- Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, OK (Fulton, Confer, Sorensen, Burge).,U.S. Department of Agriculture, Agriculture Research Service, National Animal Disease Center, Ames, IA (Ridpath)
| | - Nicholas J Sorensen
- Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, OK (Fulton, Confer, Sorensen, Burge).,U.S. Department of Agriculture, Agriculture Research Service, National Animal Disease Center, Ames, IA (Ridpath)
| | - Julia F Ridpath
- Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, OK (Fulton, Confer, Sorensen, Burge).,U.S. Department of Agriculture, Agriculture Research Service, National Animal Disease Center, Ames, IA (Ridpath)
| | - Lurinda J Burge
- Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, OK (Fulton, Confer, Sorensen, Burge).,U.S. Department of Agriculture, Agriculture Research Service, National Animal Disease Center, Ames, IA (Ridpath)
| |
Collapse
|
13
|
Vaccination of cattle against bovine viral diarrhea virus. Vet Microbiol 2017; 206:78-83. [PMID: 28400145 DOI: 10.1016/j.vetmic.2017.04.003] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Revised: 04/04/2017] [Accepted: 04/05/2017] [Indexed: 11/23/2022]
Abstract
Bovine viral diarrhea virus (BVDV) is responsible for significant losses to the cattle industry. Currently, modified-live viral (MLV) and inactivated viral vaccines are available against BVDV, often in combination with other viral and bacterial antigens. Inactivated and MLV vaccines provide cattle producers and veterinarians safe and efficacious options for herd immunization to limit disease associated with BVDV infection. Vaccination of young cattle against BVDV is motivated by prevention of clinical disease and limiting viral spread to susceptible animals. For reproductive-age cattle, vaccination to prevent viremia and birth of persistently infected offspring is considered more important, while also more difficult to achieve than prevention of clinical disease. Recent advances have been made in the understanding of BVDV vaccine efficacy. In terms of preventing clinical disease, current BVDV vaccines have been demonstrated to have a rapid onset of immunity and MLV vaccines can be effectively utilized in calves possessing maternal immunity. For reproductive protection, more recent studies using multivalent MLV vaccines have demonstrated consistent fetal protection rates in the range of 85-100% in experimental studies. Proper timing and administration of BVDV vaccines can be utilized to maximize vaccine efficacy to provide an important contribution to reducing risks associated with BVDV infection. With improvements in vaccine formulations and increased understanding of the protective immune response following vaccination, control of BVDV through vaccination can be enhanced.
Collapse
|
14
|
Mahan SM, Sobecki B, Johnson J, Oien NL, Meinert TR, Verhelle S, Mattern SJ, Bowersock TL, Leyh RD. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease. J Am Vet Med Assoc 2017; 248:1280-6. [PMID: 27172345 DOI: 10.2460/javma.248.11.1280] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To evaluate efficacy and duration of immunity of the bovine herpesvirus type 1 (BHV-1) fraction of a trivalent vaccine also containing parainfluenza virus-3 and bovine respiratory syncytial virus fractions administered intranasally (IN) for protection of calves against infectious bovine rhinotracheitis (IBR). DESIGN Controlled challenge study. ANIMALS 120 dairy calves (3 to 8 days old) seronegative for antibody against BHV-1 (experiments 1 and 2) or seropositive for maternally derived antibody against BHV-1 (experiment 3). PROCEDURES In 3 separate experiments, calves were vaccinated IN via 2 nostrils (experiment 1) or 1 nostril (experiments 2 and 3) with a vaccine containing or not containing a BHV-1 fraction. For seronegative calves, the test vaccine contained a minimum immunizing dose of BHV-1; for seropositive calves, it contained a commercial dose of BHV-1. Calves were challenged IN with virulent BHV-1 on day 28 or 193 (seronegative calves) or day 105 (seropositive calves) after vaccination to evaluate vaccine efficacy. Frequency and duration of clinical signs, rectal temperatures, virus shedding, and serologic responses were compared between treatment groups within experiments. RESULTS In all experiments, BHV-1 vaccinated calves had lower frequencies or shorter durations of clinical signs of IBR than did control calves. Following viral challenge, peak rectal temperatures and degrees of virus shedding were lower and serologic responses were higher in vaccinated versus control calves. CONCLUSIONS AND CLINICAL RELEVANCE IN vaccination against BHV-1 protected all calves against clinical IBR disease, regardless of serologic status at the time of vaccination, and suppressed virus shedding. A single dose of this IN vaccine has the potential to protect seronegative calves for at least 193 days and override maternally derived antibody to protect seropositive calves for at least 105 days.
Collapse
|
15
|
Packianathan R, Clough WJ, Hodge A, Holz DK, Huang J, Bryant GL, Colantoni C. Prevention of fetal infection in heifers challenged with bovine viral diarrhoea virus type 1a by vaccination with a type 1c or type 1a vaccine. N Z Vet J 2017; 65:134-139. [PMID: 28359226 DOI: 10.1080/00480169.2017.1291376] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
AIMS To evaluate a vaccine containing type 1c bovine viral diarrhoea (BVD) virus for prevention of fetal infection in pregnant heifers when challenged with New Zealand BVD virus type 1a 6 months after vaccination, compared to unvaccinated heifers and heifers vaccinated with a vaccine containing type 1a BVD virus. METHODS Fifty five crossbred Friesian heifers, free from BVD virus and antibody, were randomly allocated to three groups. Twenty five heifers were vaccinated twice with a vaccine containing type 1c BVD virus (T1c group), and 10 heifers with a vaccine containing type 1a BVD virus (T1a group), and 20 heifers were unvaccinated (NC group). After oestrus synchronisation the heifers were bred by artificial insemination followed by natural bull mating. Six months after booster vaccination 15 heifers from the T1c group, eight from the T1a group, and 15 from the NC group, were exposed to four calves that were persistently infected with type 1a BVD virus, for 4 weeks. At the beginning of the challenge phase 36/38 heifers were 72-74 days pregnant and 2/38 heifers were approximately 53 days pregnant. Approximately 52 days after the start of the challenge the heifers were subjected to euthanasia and fetal tissues were collected for the detection of BVD virus by ELISA in fetal heart blood and PCR in fetal tissues. RESULTS Based on PCR results, BVD virus was detected in 15/15 fetuses in the NC group, compared to 4/14 fetuses in the T1c group and 3/8 fetuses in the T1a group. The proportion of BVD virus-positive fetuses was lower in both vaccinated groups compared to the NC group (p<0.002), but there was no difference in proportions between the vaccinated groups (p=1.00). Fetal protection, expressed as the prevented fraction, was 71.4 (95% CI=41.9-91.6)% and 62.5 (95% CI=24.5-91.5)% for the T1c and T1a groups, respectively. CONCLUSIONS AND CLINICAL RELEVANCE The vaccines containing killed type 1c and type 1a BVD viruses significantly reduced fetal infection following challenge with a New Zealand type 1a BVD virus. Prevention of fetal infection by vaccination may not be 100%, and the risk of persistently infected calves being born to some vaccinated cattle should be acknowledged and managed as part of a BVD control programme.
Collapse
Affiliation(s)
- R Packianathan
- a Veterinary Medicines Research and Development , Zoetis Australia Research and Manufacturing Pty Ltd , Level 6, 5 Rider Boulevard, Rhodes , NSW 2138 , Australia
| | - W J Clough
- b Zoetis New Zealand Ltd , PO Box 2094, Shortland Street, Auckland , 1140 , New Zealand
| | - A Hodge
- a Veterinary Medicines Research and Development , Zoetis Australia Research and Manufacturing Pty Ltd , Level 6, 5 Rider Boulevard, Rhodes , NSW 2138 , Australia
| | - D K Holz
- b Zoetis New Zealand Ltd , PO Box 2094, Shortland Street, Auckland , 1140 , New Zealand
| | - J Huang
- a Veterinary Medicines Research and Development , Zoetis Australia Research and Manufacturing Pty Ltd , Level 6, 5 Rider Boulevard, Rhodes , NSW 2138 , Australia
| | - G L Bryant
- a Veterinary Medicines Research and Development , Zoetis Australia Research and Manufacturing Pty Ltd , Level 6, 5 Rider Boulevard, Rhodes , NSW 2138 , Australia
| | - C Colantoni
- a Veterinary Medicines Research and Development , Zoetis Australia Research and Manufacturing Pty Ltd , Level 6, 5 Rider Boulevard, Rhodes , NSW 2138 , Australia
| |
Collapse
|
16
|
Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine. Vaccine 2017; 35:1046-1054. [PMID: 28111144 DOI: 10.1016/j.vaccine.2017.01.006] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2016] [Revised: 01/03/2017] [Accepted: 01/04/2017] [Indexed: 11/23/2022]
Abstract
The objective of this study was to compare reproductive protection in cattle against bovine viral diarrhea virus (BVDV) and bovine herpesvirus 1 (BoHV-1) provided by annual revaccination with multivalent modified-live viral (MLV) vaccine or multivalent combination viral (CV) vaccine containing temperature-sensitive modified-live BoHV-1 and killed BVDV when MLV vaccines were given pre-breeding to nulliparous heifers. Seventy-five beef heifers were allocated into treatment groups A (n=30; two MLV doses pre-breeding, annual revaccination with MLV vaccine), B (n=30; two MLV doses pre-breeding, annual revaccination with CV vaccine) and C (n=15; saline in lieu of vaccine). Heifers were administered treatments on days 0 (weaning), 183 (pre-breeding), 366 (first gestation), and 738 (second gestation). After first calving, primiparous cows were bred, with pregnancy assessment on day 715. At that time, 24 group A heifers (23 pregnancies), 23 group B heifers (22 pregnancies), and 15 group C heifers (15 pregnancies) were commingled with six persistently infected (PI) cattle for 16days. Ninety-nine days after PI removal, cows were intravenously inoculated with BoHV-1. All fetuses and live offspring were assessed for BVDV and BoHV-1. Abortions occurred in 3/23 group A cows, 1/22 group B cows, and 11/15 group C cows. Fetal infection with BVDV or BoHV-1 occurred in 4/23 group A offspring, 0/22 group B offspring, and 15/15 group C offspring. This research demonstrates efficacy of administering two pre-breeding doses of MLV vaccine with annual revaccination using CV vaccine to prevent fetal loss due to exposure to BVDV and BoHV-1.
Collapse
|
17
|
Newcomer BW, Givens D. Diagnosis and Control of Viral Diseases of Reproductive Importance: Infectious Bovine Rhinotracheitis and Bovine Viral Diarrhea. Vet Clin North Am Food Anim Pract 2016; 32:425-41. [PMID: 27140298 DOI: 10.1016/j.cvfa.2016.01.011] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
Both bovine viral diarrhea virus and bovine herpesvirus 1 can have significant negative reproductive impacts on cattle health. Vaccination is the primary control method for the viral pathogens in US cattle herds. Polyvalent, modified-live vaccines are recommended to provide optimal protection against various viral field strains. Of particular importance to bovine viral diarrhea control is the limitation of contact of pregnant cattle with potential viral reservoirs during the critical first 125 days of gestation.
Collapse
Affiliation(s)
- Benjamin W Newcomer
- Department of Pathobiology, College of Veterinary Medicine, Auburn University, 127 Sugg Laboratory, Auburn, AL 36849-5516, USA
| | - Daniel Givens
- Office of Academic Affairs, College of Veterinary Medicine, Auburn University, 217 Veterinary Education Center, Auburn, AL 36849-5536, USA.
| |
Collapse
|
18
|
Abstract
The control and prevention of bovine viral diarrhea virus (BVDV) infections has provided substantial challenges. Viral genetic variation, persistent infections, and viral tropism for immune cells have complicated disease control strategies. Vaccination has, however, provided an effective tool to prevent acute systemic infections and increase reproductive efficiency through fetal protection. There has been substantial controversy about the safety and efficacy of BVDV vaccines, especially when comparing killed versus modified-live viral (MLV) vaccines. Furthermore, numerous vaccination protocols have been proposed to protect the fetus and ensure maternal antibody transfer to the calf. These issues have been further complicated by reports of immune suppression during natural infections and following vaccination. While killed BVDV vaccines provide the greatest safety, their limited immunogenicity makes multiple vaccinations necessary. In contrast, MLV BVDV vaccines induce a broader range of immune responses with a longer duration of immunity, but require strategic vaccination to minimize potential risks. Vaccination strategies for breeding females and young calves, in the face of maternal antibody, are discussed. With intranasal vaccination of young calves it is possible to avoid maternal antibody interference and induce immune memory that persists for 6-8 months. Thus, with an integrated vaccination protocol for both breeding cows and calves it is possible to maximize disease protection while minimizing vaccine risks.
Collapse
|
19
|
Impact of species and subgenotypes of bovine viral diarrhea virus on control by vaccination. Anim Health Res Rev 2015; 16:40-54. [DOI: 10.1017/s1466252315000079] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
AbstractBovine viral diarrhea viruses (BVDV) are diverse genetically and antigenically. This diversity impacts both diagnostic testing and vaccination. In North America, there are two BVDV species, 1 and 2 with 3 subgentoypes, BVDV1a, BVDV1b and BVDV2a. Initially, US vaccines contained BVDV1a cytopathic strains. With the reporting of BVDV2 severe disease in Canada and the USA there was focus on protection by BVDV1a vaccines on BVDV2 disease. There was also emphasis of controlling persistently infected (PI) cattle resulted in studies for fetal protection afforded by BVDV1a vaccines. Initially, studies indicated that some BVDV1a vaccines gave less than 100% protection against BVDV2 challenge for fetal infection. Eventually vaccines in North America added BVDV2a to modified live virus (MLV) and killed BVDV1a vaccines. Ideally, vaccines should stimulate complete immunity providing 100% protection against disease, viremias, shedding, and 100% fetal protection in vaccinates when challenged with a range of diverse antigenic viruses (subgenotypes). There should be a long duration of immunity stimulated by vaccines, especially for fetal protection. MLV vaccines should be safe when given according to the label and free of other pathogens. While vaccines have now included BVDV1a and BVDV2a, with the discovery of the predominate subgenotype of BVDV in the USA to be BVDV1b, approximately 75% or greater in prevalence, protection in acute challenge and fetal protection studies became more apparent for BVDV1b. Thus many published studies examined protection by BVDV1a and BVDV2a vaccines against BVDV1b in acute challenge and fetal protection studies. There are no current BVDV1b vaccines in the USA. There are now more regulations on BVDV reproductive effects by the USDA Center for Veterinary Biologics (CVB) regarding label claims for protection against abortion, PI calves, and fetal infections, including expectations for studies regarding those claims. Also, the USDA CVB has a memorandum providing the guidance for exemption of the warning label statement against the use of the MLV BVDV in pregnant cows and calves nursing pregnant cows. In reviews of published studies in the USA, the results of acute challenge and fetal protection studies are described, including subgenotypes in vaccines and challenge strains and the results in vaccinates and the vaccinates' fetuses/newborns. In general, vaccines provide protection against heterologous strains, ranging from 100% to partial but statistically significant protection. In recent studies, the duration of immunity afforded by vaccines was investigated and reported. Issues of contamination remain, especially since fetal bovine serums may be contaminated with noncytopathic BVDV. In addition, the potential for immunosuppression by MLV vaccines exists, and new vaccines will be assessed in the future to prove those MLV components are not immunosuppressive by experimental studies. As new subgenotypes are found, the efficacy of the current vaccines should be evaluated for these new strains.
Collapse
|
20
|
Walz PH, Edmondson MA, Riddell KP, Braden TD, Gard JA, Bayne J, Joiner KS, Galik PK, Zuidhof S, Givens MD. Effect of vaccination with a multivalent modified-live viral vaccine on reproductive performance in synchronized beef heifers. Theriogenology 2015; 83:822-31. [DOI: 10.1016/j.theriogenology.2014.11.015] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2014] [Revised: 11/14/2014] [Accepted: 11/16/2014] [Indexed: 11/16/2022]
|
21
|
Newcomer BW, Walz PH, Givens MD, Wilson AE. Efficacy of bovine viral diarrhea virus vaccination to prevent reproductive disease: A meta-analysis. Theriogenology 2015; 83:360-365.e1. [DOI: 10.1016/j.theriogenology.2014.09.028] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2014] [Revised: 09/23/2014] [Accepted: 09/23/2014] [Indexed: 10/24/2022]
|
22
|
Newcomer BW, Givens MD. Approved and experimental countermeasures against pestiviral diseases: Bovine viral diarrhea, classical swine fever and border disease. Antiviral Res 2013; 100:133-50. [DOI: 10.1016/j.antiviral.2013.07.015] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2013] [Revised: 07/01/2013] [Accepted: 07/27/2013] [Indexed: 01/13/2023]
|
23
|
Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine. Theriogenology 2013; 79:1184-95. [DOI: 10.1016/j.theriogenology.2013.02.017] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2012] [Revised: 02/16/2013] [Accepted: 02/17/2013] [Indexed: 11/20/2022]
|
24
|
Rodning S, Givens M, Marley M, Zhang Y, Riddell K, Galik P, Hathcock T, Gard J, Prevatt J, Owsley W. Reproductive and economic impact following controlled introduction of cattle persistently infected with bovine viral diarrhea virus into a naive group of heifers. Theriogenology 2012; 78:1508-16. [DOI: 10.1016/j.theriogenology.2012.05.031] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2012] [Revised: 05/14/2012] [Accepted: 05/30/2012] [Indexed: 10/27/2022]
|
25
|
Measuring bovine viral diarrhea virus vaccine response: Using a commercially available ELISA as a surrogate for serum neutralization assays. Vaccine 2012; 30:6559-63. [DOI: 10.1016/j.vaccine.2012.08.047] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2012] [Revised: 07/27/2012] [Accepted: 08/19/2012] [Indexed: 11/21/2022]
|
26
|
Fulton RW. Host response to bovine viral diarrhea virus and interactions with infectious agents in the feedlot and breeding herd. Biologicals 2012; 41:31-8. [PMID: 22890128 PMCID: PMC7106515 DOI: 10.1016/j.biologicals.2012.07.009] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2012] [Revised: 07/06/2012] [Accepted: 07/09/2012] [Indexed: 11/21/2022] Open
Abstract
Bovine viral diarrhea viruses (BVDV) have significant impact on beef and dairy production worldwide. The infections are widespread in the cattle populations, and in many production systems, vaccinations are utilized. BVDV strains have the hallmark of adversely affecting the immune system's many components, both the innate and acquired systems. While BVDV do cause primary infections and disease, their role in the pathogenesis of other agents underscores the complexity of viral–bacterial synergy. A greater understanding of the role of the persistently infected (PI) animal resulting from susceptible females infected at a critical stage of pregnancy has permitted acknowledgment of a major source of infection to susceptible animals. Not only do we understand the role of the PI in transmitting infections and complicating other infections, but we now focus attempts to better diagnose and remove the PI animal. Vaccinations now address the need to have an immune population, especially the breeding females in the herd. Biosecurity, detection and removal of the PI, and effective vaccinations are tools for potential successful BVDV control.
Collapse
Affiliation(s)
- Robert W Fulton
- Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, 250 McElroy Hall, Oklahoma State University, Stillwater, OK 74078, USA.
| |
Collapse
|
27
|
Givens MD, Marley MSD, Jones CA, Ensley DT, Galik PK, Zhang Y, Riddell KP, Joiner KS, Brodersen BW, Rodning SP. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding. J Am Vet Med Assoc 2012; 241:484-95. [DOI: 10.2460/javma.241.4.484] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|